tired on retatrutide is being talked about as the next big weight loss peptide. But a Victorian RETATRUTIDE: Why some people thrive…

Key findings from animal studies Superior body weight reduction compared to GLP-1 monoagonists in diet-induced obese rodent models Significant reduction in hepatic fat content in NASH models, suggesting relevance for metabolic liver disease research Improvements in lipid profiles (triglycerides, LDL cholesterol) beyond what was observed with GLP-1 monoagonism alone Evidence of increased energy expenditure supporting the glucagon receptor-mediated thermogenesis hypothesis Clinical Research Timeline (Updated Through 2026) Retatrutide has now progressed through Phase 3 clinical trials with three major readouts between December 2025 and May 2026, representing the most advanced clinical development of any triple hormone receptor agonist to date

But it doesnt contain GLP-1, and it doesnt work the way a GLP-1 medication does

Solubility Information Important: Due to its hydrophobic nature, Dihexa does not dissolve in pure water and must be mixed with a suitable solvent such as DMSO

Han D, Hanawa N, Saberi B, Kaplowitz N

E.SadekK

I do not discourage patients from using BPC-157 for its documented properties (gut healing, tissue repair) if they understand the risks